PDX1^LOW MAFA^LOW β-cells contribute to islet function and insulin release

Area of Science:

• Endocrinology
• Cell Biology
• Metabolic Research

Background:

• Adult islets contain a mix of transcriptionally mature and immature beta-cells.
• The functional contribution of this beta-cell heterogeneity to insulin secretion is not well understood.

Purpose of the Study:

• To investigate how differences in beta-cell maturity, defined by PDX1 and MAFA expression, influence islet operation and insulin release.
• To explore the role of calcium (Ca2+) signaling in regulating beta-cell maturity and islet function.

Main Methods:

• Functional mapping of rodent and human islets with varying PDX1 and MAFA expression levels.
• Transcriptomic analysis to identify dysregulated gene pathways.
• Chemogenetic disruption strategies to assess the dependence of PDX1/MAFA differences on Ca2+ signaling.

Main Results:

• Islets with higher proportions of PDX1HIGH and MAFAHIGH beta-cells exhibit impaired metabolism, ionic fluxes, and insulin secretion.
• Increased PDX1HIGH and MAFAHIGH beta-cells correlate with dysregulated metabolic gene pathways.
• PDX1 and MAFA expression patterns are influenced by islet Ca2+ signaling dynamics.
• Metabolic stress-induced islet dysfunction can be reversed by rebalancing PDX1 and MAFA levels.

Conclusions:

• Subtle variations in beta-cell maturity, indicated by PDX1 and MAFA expression, are crucial for normal islet function.
• Maintaining heterogeneity in PDX1 and MAFA expression is vital for preserving overall islet health and insulin secretion.
• Targeting beta-cell maturity balance may offer therapeutic strategies for metabolic disorders.